Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth

Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth<i>Salmonella</i>-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth, Published online: 01 March 2019; doi:10.1038/s41417-019-0089-7Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth

https://www.nature.com/articles/s41417-019-0089-7

Source: Cancer Gene Therapy - March 1, 2019 Category: Cancer & Oncology Authors: Thuy Phan Vu H. Nguyen Marcela S. D ’Alincourt Edwin R. Manuel Teodora Kaltcheva Weimin Tsai Bruce R. Blazar Don J. Diamond Laleh G. Melstrom Source Type: research